ফুসফুসের ক্যানসার (non-small cell)
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
কোথায় যেতে হবে
এই ট্রায়ালের জন্য ভারতের ৬টি হাসপাতাল রোগী নিচ্ছে।
রেজিস্ট্রির সারসংক্ষেপ (টেকনিক্যাল)
The purpose of this study is to understand if PF-08046054 alone works well compared to standard-of-care docetaxel alone in participants with non-small cell lung cancer (NSCLC) with PD-L1 expression greater than or equal to 1% and had cancer progression during or after treatment with PD-L1 or PD-1 inhibitors, platinum-based chemotherapy, and targeted treatment regimen(s) for participants with known actionable genomic alterations (AGAs). Participants in this study must have cancer that has spread through their body or can't be removed with surgery or treated with definitive radiation. Participa…
Sponsor: Pfizer
ClinicalTrials.gov-এ NCT07144280
রেজিস্ট্রিতে শেষ আপডেট 13 Oct 2026 · আমাদের পড়া 20 Oct 2026